Company Filing History:
Years Active: 2003
Title: Hanse-Michael Eggenweiler: Innovator in Phosphodiesterase Inhibition
Introduction
Hanse-Michael Eggenweiler is a notable inventor based in Weiterstadt, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of phosphodiesterase inhibitors. His work is recognized for its potential therapeutic applications.
Latest Patents
Hanse-Michael holds a patent for "Imidazopyridine derivatives as phosphodiesterase VII inhibitors." This innovation highlights his expertise in creating compounds that may have important implications in treating various medical conditions.
Career Highlights
He is currently associated with Merck Patent Gesellschaft mit beschränkter Haftung, where he continues to advance his research and development efforts. His work at Merck has positioned him as a key player in the pharmaceutical industry.
Collaborations
Hanse-Michael has collaborated with esteemed colleagues such as Karl-August Ackermann and Rochust Jonas. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Hanse-Michael Eggenweiler's contributions to the field of phosphodiesterase inhibition exemplify the impact of dedicated research and innovation in medicine. His work continues to inspire advancements in therapeutic solutions.